Introducing the ultimate holistic approach to fertility, we are proud to announce a partnership today between ScreenMe®scientific, the makers of ScreenMe fertility nutrition, and Fertility Focus, the makers of the OvuFirst skin sensor, OvuSense™ fertility monitor, and OvuSense® Pro clinical screening and medication tracking tool.
Robert Milnes, CEO of Fertility Focus says, “In the face of unprecedented health and economic disruption caused by the Covid-19 pandemic, recent research shows Millennials and Gen-Z are determined more than ever to build a different future. They’ve been forced to spend much of the past year online, and the feeling of uncertainty that a pandemic brings means they want to regain some control. It’s focused their minds on key life goals, such as starting or growing a family. In fact, this online generation is the future of families, so it makes perfect sense to offer OvuSense and ScreenMe together as the ideal testing and holistic intervention solution.”
ScreenMe uses at-home testing of health markers, micronutrients, hormones, and gut health followed by tailored nutrition and guidance from doctors, nutritionists, and scientists allowing women to take control of their health and fertility and maximise their chances of success. Importance of maternal nutrition in both optimising chances of conception and long-term development of children is accepted by both the medical and scientific community and tracking important health markers with access to professional, science-based, holistic advice provides reassurance that the right steps are taken to increase chances of conception and provide the future generation with the best kickstart possible.
Also for use in the home, OvuFirst, the most accurate skin-worn sensor on the market, confirms your fertile window with over 90% accuracy. OvuFirst is designed to measure skin temperature and provide women with an understanding of when to try and conceive, and help determine what issues they may be having during the process of starting or growing a family. OvuSense’s OvuCore, which measures female continuous core body temperature (cCBT), predicts ovulation up to 24 hours in advance and confirms the exact date of ovulation with 99% clinically-proven accuracy. Based on recently published clinical studies of over 8,000 OvuSense users, the OvuSense® Pro clinical portal allows doctors to screen for potential causes of female sub-fertility, risk of miscarriage, and potential pregnancy complications, and then track the effect of changes in diet, lifestyle, and treatments.
Together, OvuSense and ScreenMe not only give women a wholesome insight into their health and fertility at an affordable price, but also provide science-based, expert holistic advice, the effects of which can be tracked by both OvuSense and ScreenMe to ensure progress.
According to Dr. Golnoush Golshirazi, CEO and Co-Founder of ScreenMe, “Investment in the health of women of reproductive age is investment into the health of the future generation. Almost half of women of reproductive age reach thirty without having had a child. Almost every one of those women, including myself, is aware of their fertility and the importance of their diet and lifestyle for a healthy conception and pregnancy today or in the future. In addition, these health-aware women are also in search of ways to better understand their body and fertility, as well as reliable sources of support and tailored holistic advice with means of knowing that advice is effective. That’s what makes the OvuSense and ScreenMe partnership the go-to solution for the increasingly health aware women who want to take back control of their health and fertility.”
Both OvuSense and ScreenMe provide you with results and insights via an App, and ScreenMe also provides virtual consultations and tailored nutrition to put you on the right track, so together they offer the best scientifically accurate holistic solution allowing women to not just monitor but optimise their fertility health at home.
Get 10% off ScreenMe and 30% off OvuSense and OvuSense® Pro with code GOFERTILITY until Dec. 31, 2021. ScreenMe is currently available in the UK. OvuSense™ and OvuSense® Pro are licensed for sale in UK, EU, USA, Canada, and Australia.
To learn more and redeem your discount, visit OvuSense at www.ovusense.com and ScreenMe at https://screenme.co.uk/.
Citations in order of appearance
Deloitte Global Millennials Survey 2020
https://www2.deloitte.com/global/en/pages/about-deloitte/articles/millennialsurvey.html
Role of nutrition in fertility
https://europepmc.org/article/med/22516697
Importance of preconception period and maternal nutrition on long-term development
https://europepmc.org/article/med/22516697
OvuSense Prediction of Ovulation
http://www.posters2view.eu/eshre2014/data/247.pdf
OvuSense explanation of accuracy
https://www.ovusense.com/clinical-information
OvuSense Pro - cycle characteristics research publications
OvuSense Pro - Remote Monitoring and Tracking of Subfertility Issues – research video
https://youtu.be/_rNA6uAeFIc
Why wellness is the millennial self-help
https://www.independent.co.uk/news/long_reads/health-and-wellbeing/wellness-millennial-self-help-self-care-love-fear-a9056946.html
For more information, contact:
Rob Milnes
Fertility Focus
Next Step Communications
Dr Golnoush Golshirazi
ScreenMe Scientific
About Fertility Focus, makers of OvuSense and OvuSense® Pro
With the ultimate goal of increasing pregnancy rates and helping women understand their fertility, Fertility Focus brings a new approach to the issue of sub-fertility diagnosis and treatment. Through its core products, OvuSense™ and OvuSense® Pro, the company provides women and their clinicians the ability to predict and confirm ovulation, as well as screen for issues associated with sub-fertility, risk of miscarriage and risk of pregnancy. No other method of fertility monitoring in the clinic or home offers these features. The company is continuously developing new technology to support women along all stages of their fertility journeys and manages the largest closed support group on Facebook for women who have PCOS and trying to conceive called, ‘PCOS Fertility Support Group’ with over 35,000 members. Driven by their own experiences with infertility, the Fertility Focus leadership group are committed to empowering women and improving the chance of successful conception. [citations as above]
About ScreenMe, makers of the ScreenMe® fertility nutrition
With a vision of a world free from preventable disease ScreenMe brings fertility nutrition knowing the ultimate form of preventative healthcare begins before conception. At ScreenMe we’re here to empower people to take direct control of their, and their children’s, lifetime health and fertility by giving them the best advice available to current science, based on their individual health needs. We’re starting our mission by investing in the nutritional health and wellbeing of couples trying to conceive, as well as pregnant women. We’ll help them to learn more about the importance of improving their reproductive health, as well as their overall health, through nutritious food tailored to their results and profile. The company is always expanding their services to empower women, at every stage of their life, to take control of their health and fertility in the most natural ways possible and hosts a radio show on the UK health radio called ‘fertility matters’. ScreenMe is driven by scientists, doctors and nutritionists whose own experience and struggles with hormonal health, endometriosis and recurrent miscarriage has committed them to providing women with the necessary testing and care in order to improve their quality of life and chances of a healthy conception and pregnancy.